Breaking Barriers: A Single Center Real World Experience with Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement

Abstract

Abstract We conducted a retrospective exploratory study evaluating factors associated with selection to receive and infusion with COVID-19 monoclonal antibodies (mAb). While priority was given to high-risk patients, patients with increased social vulnerability index (SVI) were less likely to present for infusion, raising concern that social factors created barriers to treatment.